Patient P-01597
Therapy response
Stable
Tolerance
Unstable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
89%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S14
- Day 47 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 57 GI-04 recommended — GI Support Protocol GI-04
- Day 58 Patient accepted — Started GI-04 in the companion
- Day 66 No meaningful change — GI Support Protocol GI-04
What changed?
Trajectory began diverging from predicted response on Day 47.
Primary contributors, last 14 days
- Treatment adherence+9
- Inflammatory activity+5
- Toxicity+3
What helped?
- GI Support Protocol GI-04Day 57Result: no meaningful change
LIFE OS recommendation
Dietary Support Protocol NP-02
59%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 66% showed improvement
- median effect visible after 10 days
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓65
- WearableResting HR 74 bpm
- Wearable340 steps/day
- WearableShort sleep window
- Mucosal barrier integrity ↓60
- MicrobiomeAkkermansia low → thinner mucus layer
- Daily logGI symptom score 79 and rising
- WearableSleep 5.2 h, below personal baseline
- Butyrate / short-chain fatty acid production ↓55
- MicrobiomeButyrate capacity 40/100
- Daily logFibre intake low in recent food logs
- Inflammatory signalling ↑40
- BloodInflammatory load index 71
- WearableHRV 15 ms, trending down
- Drug metabolism and exposure ↑20
- BloodToxicity index 61
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 2.7 · butyrate capacity 40/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 15 ms
- Sleep
- 5.6 h
- Steps
- 477
- Resting HR
- 73 bpm
Daily log: GI score 79, nutritional resilience 30, adherence 47.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01866 | 62% | S14 | — | — | 40 |
| P-01367 | 52% | S14 | GI-04 | no change | 51 |
| P-01407 | 50% | S14 | NP-02 | no change | 44 |
| P-01854 | 48% | S14 | ME-01 | improved | 46 |
| P-01619 | 46% | S14 | GI-04 | worsened | 38 |
| P-01760 | 46% | S14 | — | — | 42 |
| P-01762 | 46% | S14 | NP-02 | no change | 40 |
| P-01615 | 43% | S14 | ME-01 | improved | 48 |
| P-01440 | 42% | S12 | GI-04 | no change | 51 |
| P-01582 | 42% | S14 | GI-04 | no change | 45 |
| P-01655 | 42% | S14 | GI-04 | no change | 29 |
| P-01656 | 42% | S14 | ME-01 | improved | 41 |